ArticleFuture microbiology2021

Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment.

Laura Kate Gadanec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.